ticlopidine has been researched along with Drug Hypersensitivity in 46 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the study was to assess the antiplatelet activity and safety of a combined antiplatelet treatment with indobufen and clopidogrel in acute coronary syndrome (ACS) patients with hypersensitivity to aspirin, undergoing coronary stenting." | 9.17 | Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. ( Acconcia, MC; Barillà, F; Dominici, T; Gaudio, C; Mangieri, E; Paravati, V; Pellicano, M; Pulcinelli, FM; Tanzilli, G; Torromeo, C, 2013) |
| " To assess the efficacy and safety of aspirin desensitisation in Chinese patients with coronary artery disease." | 7.79 | Aspirin desensitisation for Chinese patients with coronary artery disease. ( Chan, HL; Chan, KK; Chau, CH; Cheung, CY; Cheung, GS; Choi, MC; Lee, JK; Li, SK; Tsui, KL; Wu, KL, 2013) |
| "To characterize the clinical presentation of a cohort of patients with coronary artery disease (CAD) and aspirin reactions." | 7.79 | Characterization of aspirin allergies in patients with coronary artery disease. ( Feng, CH; Stevenson, DD; White, AA, 2013) |
| "We report a case of a severe hypersensitivity syndrome reaction to clopidogrel that resolved with dechallenge and recurred on rechallenge." | 7.73 | Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia. ( Begg, EJ; Bridgman, P; Doogue, MP, 2005) |
| "Kounis syndrome is the concurrence of acute coronary syndrome with allergic reactions, such as anaphylaxis or anaphylactoid reactions." | 5.42 | An Extraordinary Case Associated with an Allergic Reaction to Clopidogrel: Coronary Artery Spasm or Kounis Syndrome? ( Bin, H; Liping, Z; Qiming, F, 2015) |
| " Because of better side-effect profile and simpler dosing regime, clopidogrel has largely replaced ticlopidine." | 5.31 | Isolated profound thrombocytopenia associated with clopidogrel. ( Elmi, F; Peacock, T; Schiavone, J, 2000) |
| " The aim of the study was to assess the antiplatelet activity and safety of a combined antiplatelet treatment with indobufen and clopidogrel in acute coronary syndrome (ACS) patients with hypersensitivity to aspirin, undergoing coronary stenting." | 5.17 | Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. ( Acconcia, MC; Barillà, F; Dominici, T; Gaudio, C; Mangieri, E; Paravati, V; Pellicano, M; Pulcinelli, FM; Tanzilli, G; Torromeo, C, 2013) |
| " The antiplatelet agent clopidogrel has become a mainstay of treatment for patients with acute coronary syndromes and stroke, and to reduce ischemic complications after percutaneous coronary and peripheral interventions." | 5.12 | Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience. ( Fasano, MB; Horwitz, PA; Walker, NE, 2006) |
| " As for SCARs, associations of HLA-B*15:02 or HLA-A*31:01 and HLA-B*58:01 have been revealed for carbamazepine- and allopurinol-related Stevens-Johnson syndrome and toxic epidermal neclolysis, respectively." | 4.89 | Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury. ( Kaniwa, N; Saito, Y, 2013) |
| " To assess the efficacy and safety of aspirin desensitisation in Chinese patients with coronary artery disease." | 3.79 | Aspirin desensitisation for Chinese patients with coronary artery disease. ( Chan, HL; Chan, KK; Chau, CH; Cheung, CY; Cheung, GS; Choi, MC; Lee, JK; Li, SK; Tsui, KL; Wu, KL, 2013) |
| "To characterize the clinical presentation of a cohort of patients with coronary artery disease (CAD) and aspirin reactions." | 3.79 | Characterization of aspirin allergies in patients with coronary artery disease. ( Feng, CH; Stevenson, DD; White, AA, 2013) |
| "Thienopyridines, specifically clopidogrel, are the standard of care for prevention of coronary stent thrombosis; however, there are few data available on cross-hypersensitivity between these agents." | 3.77 | Use of prasugrel in a patient with clopidogrel hypersensitivity. ( Beddingfield, R; Held-Godgluck, BM; Peppard, SR, 2011) |
| "We report a case of a severe hypersensitivity syndrome reaction to clopidogrel that resolved with dechallenge and recurred on rechallenge." | 3.73 | Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia. ( Begg, EJ; Bridgman, P; Doogue, MP, 2005) |
| "Ticlopidine was subsequently discontinued due to severe diarrhea." | 2.44 | Clopidogrel desensitization: case report and review of published protocols. ( Garner, J; Hergott, L; Owen, P; Page, RL, 2008) |
| "Kounis syndrome is the concurrence of acute coronary syndrome with allergic reactions, such as anaphylaxis or anaphylactoid reactions." | 1.42 | An Extraordinary Case Associated with an Allergic Reaction to Clopidogrel: Coronary Artery Spasm or Kounis Syndrome? ( Bin, H; Liping, Z; Qiming, F, 2015) |
| " Because of better side-effect profile and simpler dosing regime, clopidogrel has largely replaced ticlopidine." | 1.31 | Isolated profound thrombocytopenia associated with clopidogrel. ( Elmi, F; Peacock, T; Schiavone, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.17) | 18.2507 |
| 2000's | 15 (32.61) | 29.6817 |
| 2010's | 30 (65.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramotowski, B | 1 |
| Żuk, A | 1 |
| Budaj, A | 1 |
| Consolo, F | 1 |
| Pozzi, L | 1 |
| Sferrazza, G | 1 |
| Della Valle, P | 1 |
| D'Angelo, A | 1 |
| Slepian, MJ | 1 |
| Pappalardo, F | 1 |
| Felix-Getzik, E | 1 |
| Sylvia, LM | 1 |
| Kaniwa, N | 1 |
| Saito, Y | 1 |
| Lee, JK | 1 |
| Tsui, KL | 1 |
| Cheung, CY | 1 |
| Chau, CH | 1 |
| Chan, HL | 1 |
| Wu, KL | 1 |
| Cheung, GS | 1 |
| Choi, MC | 1 |
| Chan, KK | 1 |
| Li, SK | 1 |
| Veas P, N | 1 |
| Martínez, G | 1 |
| Jalil M, J | 1 |
| Martínez S, A | 1 |
| Castro G, P | 1 |
| Barreira, P | 1 |
| Cadinha, S | 1 |
| Malheiro, D | 1 |
| Moreira da Silva, JP | 1 |
| Manchette, AM | 1 |
| Drucker, AG | 1 |
| Januzzi, JL | 1 |
| Beavers, CJ | 1 |
| Carris, NW | 1 |
| Ruf, KM | 1 |
| Liping, Z | 1 |
| Bin, H | 1 |
| Qiming, F | 1 |
| Siu, H | 1 |
| Kaliyadan, A | 1 |
| Fischman, DL | 2 |
| Nardone, E | 1 |
| Poll, D | 1 |
| Savage, MP | 2 |
| Cubero, JL | 1 |
| Simó Sánchez, B | 1 |
| Millán, P | 1 |
| Colás, C | 1 |
| Fajt, M | 1 |
| Petrov, A | 1 |
| Lokhandwala, JO | 1 |
| Best, PJ | 2 |
| Butterfield, JH | 1 |
| Skelding, KA | 1 |
| Scott, T | 1 |
| Blankenship, JC | 1 |
| Buckley, JW | 1 |
| Berger, PB | 2 |
| Karabay, CY | 1 |
| Can, MM | 1 |
| Tanboğa, IH | 1 |
| Ahmet, G | 1 |
| Bitigen, A | 1 |
| Serebruany, V | 1 |
| Fernando, SL | 1 |
| Assaad, NN | 1 |
| van Werkum, JW | 1 |
| Braber, TL | 1 |
| Verheggen, PW | 1 |
| Van Der Have-Roeffel, SM | 1 |
| Lokhandwala, J | 1 |
| Henry, Y | 1 |
| Campbell, KL | 1 |
| Cohn, JR | 1 |
| Walinsky, P | 1 |
| Mallya, R | 1 |
| Jaffrani, W | 1 |
| Barison, A | 1 |
| de Carlo, M | 1 |
| Bellini, F | 1 |
| Capozza, PF | 1 |
| Lunardini, A | 1 |
| Petronio, AS | 1 |
| Peppard, SR | 1 |
| Held-Godgluck, BM | 1 |
| Beddingfield, R | 1 |
| Cheema, AN | 1 |
| Mohammad, A | 1 |
| Hong, T | 1 |
| Jakubovic, HR | 1 |
| Parmar, GS | 1 |
| Sharieff, W | 1 |
| Garvey, MB | 1 |
| Kutryk, MJ | 1 |
| Fam, NP | 1 |
| Graham, JJ | 1 |
| Chisholm, RJ | 1 |
| Gurbel, PA | 1 |
| Jeong, YH | 1 |
| Tantry, US | 1 |
| Estefanell-Tejero, A | 2 |
| López-Cabezas, C | 2 |
| Riu-Viladoms, G | 2 |
| Falces-Salvador, C | 2 |
| Chopra, P | 1 |
| Verma, P | 1 |
| Klaustermeyer, WB | 1 |
| Mutnick, JL | 1 |
| Fernández-Ruiz, M | 1 |
| Carbonell-Porras, A | 1 |
| García-Reyne, A | 1 |
| López-Medrano, F | 1 |
| Barillà, F | 1 |
| Pulcinelli, FM | 1 |
| Mangieri, E | 1 |
| Torromeo, C | 1 |
| Tanzilli, G | 1 |
| Dominici, T | 1 |
| Pellicano, M | 1 |
| Paravati, V | 1 |
| Acconcia, MC | 1 |
| Gaudio, C | 1 |
| Matheu, V | 1 |
| González-Pérez, R | 1 |
| Poza, P | 1 |
| Sánchez-Machín, I | 1 |
| Feng, CH | 1 |
| White, AA | 1 |
| Stevenson, DD | 1 |
| Pasternak, R | 1 |
| Lee, TH | 1 |
| Silberman, S | 1 |
| Neukirch-Stoop, C | 1 |
| Steg, PG | 1 |
| Doogue, MP | 1 |
| Begg, EJ | 1 |
| Bridgman, P | 1 |
| Walker, NE | 2 |
| Fasano, MB | 2 |
| Horwitz, PA | 2 |
| Satish, B | 1 |
| Tressa, K | 1 |
| Harish, CR | 1 |
| Hobbs, RA | 1 |
| Shaker, M | 1 |
| Lobb, A | 1 |
| Jenkins, P | 1 |
| O'Rourke, D | 1 |
| Takemoto, SK | 1 |
| Sheth, S | 1 |
| Burroughs, T | 1 |
| Dykewicz, MS | 1 |
| von Tiehl, KF | 1 |
| Price, MJ | 1 |
| Valencia, R | 1 |
| Ludington, KJ | 1 |
| Teirstein, PS | 1 |
| Simon, RA | 1 |
| Owen, P | 1 |
| Garner, J | 1 |
| Hergott, L | 1 |
| Page, RL | 1 |
| Hobbs, L | 1 |
| Lyle, B | 1 |
| Shimizu, A | 1 |
| Koyama, M | 1 |
| Miyazaki, K | 1 |
| Tagawa, S | 1 |
| Takase, K | 1 |
| Nakano, T | 1 |
| Tameda, Y | 1 |
| Kosaka, Y | 1 |
| Fork, FT | 1 |
| Lafolie, P | 1 |
| Tóth, E | 1 |
| Lindgärde, F | 1 |
| Elmi, F | 1 |
| Peacock, T | 1 |
| Schiavone, J | 1 |
| Sarrot-Reynauld, F | 1 |
| Bouillet, L | 1 |
| Bourrain, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analysis of the Platelet Activity State in Patients Implanted With Ventricular Assist Device (VAD)[NCT03255928] | 60 participants (Anticipated) | Observational [Patient Registry] | 2017-06-29 | Recruiting | |||
| Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer[NCT02418312] | 228 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| Pantoprazole Versus Famotidine for the Prevention of Recurrent Peptic Ulcers in Thienopyridine Users - a Double-blind Randomized Controlled Trial[NCT02551744] | 101 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Follow-up endoscopy was performed at the end of the 6th month (NCT02418312)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Histamine-2 Receptor Antagonist Group | 106 |
| Placebo Group | 101 |
Follow-up endoscopy was performed at the end of the 6th month (NCT02551744)
Timeframe: six month
| Intervention | participants (Number) |
|---|---|
| Proton Pump Inhibitor Group | 1 |
| Histamine-2 Receptor Antagonist Group | 7 |
5 reviews available for ticlopidine and Drug Hypersensitivity
| Article | Year |
|---|---|
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Topics: Alleles; Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Azetidines; Benzylamines; Carba | 2013 |
Management Strategies for Clopidogrel Hypersensitivity.
Topics: Clopidogrel; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Platelet Aggregation Inhib | 2015 |
Use of prasugrel in the setting of clopidogrel hypersensitivity: Case report and systematic review of the literature.
Topics: Adult; Clopidogrel; Coronary Artery Disease; Drug Hypersensitivity; Drug Substitution; Drug-Eluting | 2016 |
Clopidogrel desensitization: case report and review of published protocols.
Topics: Cardiac Catheterization; Clinical Protocols; Clopidogrel; Coronary Artery Disease; Desensitization, | 2008 |
[A case report of drug induced hepatitis and pancreatitis].
Topics: Aged; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; Fibrinolytic Agents; Hu | 1997 |
4 trials available for ticlopidine and Drug Hypersensitivity
| Article | Year |
|---|---|
Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combinatio | 2013 |
Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
Topics: Adult; Aged; Clopidogrel; Coronary Disease; Desensitization, Immunologic; Dose-Response Relationship | 2006 |
Clopidogrel desensitization after drug-eluting stent placement.
Topics: Clopidogrel; Coronary Artery Disease; Desensitization, Immunologic; Drug Hypersensitivity; Drug-Elut | 2007 |
Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study.
Topics: Adult; Aspirin; Clopidogrel; Double-Blind Method; Drug Hypersensitivity; Gastric Mucosa; Gastritis; | 2000 |
Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study.
Topics: Adult; Aspirin; Clopidogrel; Double-Blind Method; Drug Hypersensitivity; Gastric Mucosa; Gastritis; | 2000 |
Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study.
Topics: Adult; Aspirin; Clopidogrel; Double-Blind Method; Drug Hypersensitivity; Gastric Mucosa; Gastritis; | 2000 |
Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study.
Topics: Adult; Aspirin; Clopidogrel; Double-Blind Method; Drug Hypersensitivity; Gastric Mucosa; Gastritis; | 2000 |
37 other studies available for ticlopidine and Drug Hypersensitivity
| Article | Year |
|---|---|
Repetitive stent thrombosis in a patient with suspected allergy to aspirin and multiple switch between clopidogrel, prasugrel, and ticagrelor.
Topics: Adenosine; Aspirin; Clopidogrel; Coronary Vessels; Drug Hypersensitivity; Humans; Male; Middle Aged; | 2017 |
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?
Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Heart Failure; Heart-Assist | 2018 |
Prasugrel use in a patient allergic to clopidogrel: effect of a drug shortage on selection of dual antiplatelet therapy.
Topics: Aged; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Female; Follow-Up Studies; Huma | 2013 |
Aspirin desensitisation for Chinese patients with coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Angiography; Coronary | 2013 |
[Rapid aspirin desensitization in patients with a history of aspirin hypersensitivity requiring coronary angioplasty. Report of four cases].
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Desensitization, Immunologic; Drug Hyper | 2013 |
Desensitization to clopidogrel: a tailor-made protocol.
Topics: Aged; Clopidogrel; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Male; Platelet Aggre | 2014 |
Acute coronary syndrome antiplatelet alternatives in clopidogrel allergy.
Topics: Acute Coronary Syndrome; Adenosine; Adult; Aged; Clopidogrel; Drug Hypersensitivity; Female; Humans; | 2014 |
An Extraordinary Case Associated with an Allergic Reaction to Clopidogrel: Coronary Artery Spasm or Kounis Syndrome?
Topics: Acute Coronary Syndrome; Clopidogrel; Coronary Vasospasm; Drug Hypersensitivity; Humans; Male; Middl | 2015 |
Aspirin desensitization in patients with coronary artery disease: Cost savings.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost Savings; Desensitization, Immunologic; Drug Hypersensit | 2017 |
Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Topics: Administration, Oral; Adult; Aged; Clopidogrel; Desensitization, Immunologic; Drug Hypersensitivity; | 2010 |
Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.
Topics: Aged; Angioedema; Clopidogrel; Drug Hypersensitivity; Exanthema; Female; Humans; Male; Neutropenia; | 2009 |
Recurrent acute stent thrombosis due to allergic reaction secondary to clopidogrel therapy.
Topics: Acute Disease; Adult; Clopidogrel; Coronary Thrombosis; Drug Hypersensitivity; Humans; Male; Platele | 2011 |
Rapid and sequential desensitization to both aspirin and clopidogrel.
Topics: Angioedema; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; H | 2010 |
Prasugrel as alternative treatment strategy in a case with a hypersensitivity reaction to clopidogrel.
Topics: Aged; Angioedema; Clopidogrel; Drug Hypersensitivity; Exanthema; Fever; Humans; Male; Piperazines; P | 2011 |
Allergic reactions to clopidogrel and cross-reactivity to other agents.
Topics: Adrenal Cortex Hormones; Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Desensitizatio | 2011 |
Management of clopidogrel hypersensitivity without drug interruption.
Topics: Adrenal Cortex Hormones; Cardiac Catheterization; Clopidogrel; Coronary Thrombosis; Drug Hypersensit | 2011 |
Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Occlusion; Coronary Thrombosis; Drug | 2011 |
Use of prasugrel in a patient with clopidogrel hypersensitivity.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Drug Hypersensitivity; Humans; Male; Middle Aged; Myoca | 2011 |
Characterization of clopidogrel hypersensitivity reactions and management with oral steroids without clopidogrel discontinuation.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Disease Management; Drug Hy | 2011 |
Cutaneous clopidogrel hypersensitivity: give steroids and do not stop the clopidogrel.
Topics: Clopidogrel; Drug Hypersensitivity; Female; Humans; Male; Prednisone; Ticlopidine | 2011 |
[Efficacy and tolerability of a clopidogrel desensitization protocol].
Topics: Aged; Aged, 80 and over; Clopidogrel; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensit | 2012 |
Successful use of prasugrel, an alternative antiplatelet agent, in a patient with clopidogrel allergy.
Topics: Clopidogrel; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Male; Middle Aged; Piperazi | 2011 |
Desensitization to prasugrel: cardiology's increased need for allergy consultation.
Topics: Atherectomy, Coronary; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Artery Disease; D | 2012 |
Management of a hypersensitivity reaction to thienopyridines: prasugrel-induced fever and hepatitis resolved after switching to clopidogrel.
Topics: Adult; Clopidogrel; Coronary Artery Disease; Drug Hypersensitivity; Female; Fever; Humans; Piperazin | 2012 |
[Reply].
Topics: Desensitization, Immunologic; Drug Hypersensitivity; Humans; Male; Platelet Aggregation Inhibitors; | 2013 |
[Desensitization versus clinical tolerance].
Topics: Desensitization, Immunologic; Drug Hypersensitivity; Humans; Male; Platelet Aggregation Inhibitors; | 2013 |
Characterization of aspirin allergies in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Aspirin; California; Cardiovascular Diseases; Clopidogrel; Coronary Artery | 2013 |
Ask the doctor. Almost every day I read how important it is for people with heart disease to take an aspirin. Unfortunately, I am allergic to aspirin. There must be others with the same problem. Are there viable alternatives to aspirin? It's discouraging
Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Fatty Acids, Omega-3; Humans; Myocardial Infarction; Pl | 2003 |
By the way, doctor. I'm 74 and in good health with no apparent heart problems. Because I am allergic to aspirin, it has been suggested that I take Plavix. Your thoughts?
Topics: Aged; Aspirin; Clopidogrel; Drug Hypersensitivity; Humans; Platelet Aggregation Inhibitors; Ticlopid | 2004 |
Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Artery Disease; Desensitization, Immu | 2005 |
Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Drug Hypersensitivity; Female; | 2005 |
Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Disease Progression; Drug H | 2007 |
Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Clinical Protocols; Clopidogrel; Desensitization, Immuno | 2007 |
An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Cardiovascular Diseases; Clopidogre | 2008 |
Rapid oral aspirin desensitization for patients with aspirin allergy requiring dual antiplatelet therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Hyperse | 2008 |
Isolated profound thrombocytopenia associated with clopidogrel.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Drug Hypersensitivity; Follow-Up Studies; Humans; | 2000 |
Severe hypersensitivity associated with clopidogrel.
Topics: Cholecystitis; Clopidogrel; Drug Hypersensitivity; Humans; Male; Middle Aged; Platelet Aggregation I | 2001 |